SurModics Unveils Positive PROWL Registry Data on Pounce Thrombectomy Platform at VIVA Conference

Reuters

Nov 03

<a href="https://laohu8.com/S/SRDX">SurModics</a> Unveils Positive PROWL Registry Data on Pounce Thrombectomy Platform at VIVA Conference

SurModics Inc. has announced that updated safety and performance data from the PROWL registry, involving 160 patients with symptomatic lower extremity (infrainguinal) vessels treated with the Pounce™ Thrombectomy Platform, will be presented at the 23rd Annual VIVA Conference. The presentation, titled "Real-world Clinical Outcomes and Case Insights of the Novel Pounce™ Thrombectomy Platform: Non-Aspiration Mechanical Treatment of Acute or Chronic Peripheral Arterial Thromboemboli," is scheduled for Monday, November 3, at 3:15 PM $(PST)$ at Wynn Las Vegas. The data will be discussed by Dr. Sean Lyden, Dr. Joseph Campbell, and Dr. Peter Monteleone, who are principal investigators in the PROWL registry.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SurModics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251103845842) on November 03, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2580291243"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2580291243\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2580291243?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-03 19:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2580291243","market":"nz","top_or_hot":-1,"title":"SurModics Unveils Positive PROWL Registry Data on Pounce Thrombectomy Platform at VIVA Conference","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/SRDX\">SurModics</a> Unveils Positive PROWL Registry Data on Pounce Thrombectomy Platform at VIVA Conference\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        SurModics Inc. has announced that updated safety and performance data from the PROWL registry, involving 160 patients with symptomatic lower extremity (infrainguinal) vessels treated with the Pounce™ Thrombectomy Platform, will be presented at the 23rd Annual VIVA Conference. The presentation, titled \"Real-world Clinical Outcomes and Case Insights of the Novel Pounce™ Thrombectomy Platform: Non-Aspiration Mechanical Treatment of Acute or Chronic Peripheral Arterial Thromboemboli,\" is scheduled for Monday, November 3, at 3:15 PM <a href=\"https://laohu8.com/S/PST\">$(PST)$</a> at <a href=\"https://laohu8.com/S/01128\">Wynn</a> Las Vegas. The data will be discussed by Dr. Sean Lyden, Dr. Joseph Campbell, and Dr. Peter Monteleone, who are principal investigators in the PROWL registry.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SurModics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251103845842) on November 03, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SurModics Unveils Positive PROWL Registry Data on Pounce Thrombectomy Platform at VIVA Conference</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSurModics Unveils Positive PROWL Registry Data on Pounce Thrombectomy Platform at VIVA Conference\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-03 19:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/SRDX\">SurModics</a> Unveils Positive PROWL Registry Data on Pounce Thrombectomy Platform at VIVA Conference\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        SurModics Inc. has announced that updated safety and performance data from the PROWL registry, involving 160 patients with symptomatic lower extremity (infrainguinal) vessels treated with the Pounce™ Thrombectomy Platform, will be presented at the 23rd Annual VIVA Conference. The presentation, titled \"Real-world Clinical Outcomes and Case Insights of the Novel Pounce™ Thrombectomy Platform: Non-Aspiration Mechanical Treatment of Acute or Chronic Peripheral Arterial Thromboemboli,\" is scheduled for Monday, November 3, at 3:15 PM <a href=\"https://laohu8.com/S/PST\">$(PST)$</a> at <a href=\"https://laohu8.com/S/01128\">Wynn</a> Las Vegas. The data will be discussed by Dr. Sean Lyden, Dr. Joseph Campbell, and Dr. Peter Monteleone, who are principal investigators in the PROWL registry.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SurModics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251103845842) on November 03, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SRDX","symbol_name":"SurModics","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL9zZxR2:1","article_id":"2580291243","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2580291243","pubTimestamp":1762168526,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"SurModics Inc. has announced that updated safety and performance data from the PROWL registry, involving 160 patients with symptomatic lower extremity  vessels treated with the Pounce Thrombectomy Platform, will be presented at the 23rd Annual VIVA Conference. The presentation, titled \"Real-world Clinical Outcomes and Case Insights of the Novel Pounce Thrombectomy Platform: Non-Aspiration Mechanical Treatment of Acute or Chronic Peripheral Arterial Thromboemboli,\" is scheduled for Monday, November 3, at 3:15 PM  at Wynn Las Vegas. The data will be discussed by Dr. Sean Lyden, Dr. Joseph Campbell, and Dr. Peter Monteleone, who are principal investigators in the PROWL registry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SurModics Inc","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SRDX":"SurModics","BK4082":"医疗保健设备"},"translate_title":"SurModics在VIVA会议上公布了Pounce血栓切除术平台的积极PROWL注册数据","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SRDX":0.9},"content_text":"SurModics Unveils Positive PROWL Registry Data on Pounce Thrombectomy Platform at VIVA Conference\n    \n\n        SurModics Inc. has announced that updated safety and performance data from the PROWL registry, involving 160 patients with symptomatic lower extremity (infrainguinal) vessels treated with the Pounce™ Thrombectomy Platform, will be presented at the 23rd Annual VIVA Conference. The presentation, titled \"Real-world Clinical Outcomes and Case Insights of the Novel Pounce™ Thrombectomy Platform: Non-Aspiration Mechanical Treatment of Acute or Chronic Peripheral Arterial Thromboemboli,\" is scheduled for Monday, November 3, at 3:15 PM $(PST)$ at Wynn Las Vegas. The data will be discussed by Dr. Sean Lyden, Dr. Joseph Campbell, and Dr. Peter Monteleone, who are principal investigators in the PROWL registry.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SurModics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251103845842) on November 03, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"conferences,dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}